Fundamental Analysis of PLUS THERAPEUTICS INC(NASDAQ:PSTV) stock

Fundamental Rating

Taking everything into account, PSTV scores 1 out of 10 in our fundamental rating. PSTV was compared to 588 industry peers in the Biotechnology industry. PSTV may be in some trouble as it scores bad on both profitability and health. PSTV is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

PSTV had negative earnings in the past year.

PSTV had a negative operating cash flow in the past year.

In the past 5 years PSTV always reported negative net income.

In the past 5 years PSTV always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -116.97%, PSTV is doing worse than 82.08% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-116.97%
ROE	N/A
ROIC	N/A

ROA(3y)-87.62%

ROA(5y)-76.03%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PSTV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for PSTV has been increased compared to 1 year ago.

PSTV has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, PSTV has a worse debt to assets ratio.

2.2 Solvency

PSTV has an Altman-Z score of -62.23. This is a bad value and indicates that PSTV is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of PSTV (-62.23) is worse than 94.88% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-62.23

ROIC/WACCN/A

WACC7.15%

2.3 Liquidity

PSTV has a Current Ratio of 0.92. This is a bad value and indicates that PSTV is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of PSTV (0.92) is worse than 89.59% of its industry peers.

A Quick Ratio of 0.92 indicates that PSTV may have some problems paying its short term obligations.

PSTV has a worse Quick ratio (0.92) than 88.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.92
Quick Ratio	0.92

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PSTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.05%, which is quite impressive.

Looking at the last year, PSTV shows a very strong growth in Revenue. The Revenue has grown by 2133.18%.

Measured over the past years, PSTV shows a decrease in Revenue. The Revenue has been decreasing by -5.87% on average per year.

EPS 1Y (TTM)64.05%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q74.55%

Revenue 1Y (TTM)2133.18%

Revenue growth 3Y153.95%

Revenue growth 5Y-5.87%

Revenue growth Q2Q775.33%

3.2 Future

PSTV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.09% yearly.

The Revenue is expected to grow by 70.39% on average over the next years. This is a very strong growth

EPS Next Y45.74%

EPS Next 2Y20.88%

EPS Next 3Y11.81%

EPS Next 5Y15.09%

Revenue Next Year9.16%

Revenue Next 2Y-21.54%

Revenue Next 3Y-25.99%

Revenue Next 5Y70.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PSTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year PSTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y20.88%

EPS Next 3Y11.81%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PSTV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PLUS THERAPEUTICS INC

NASDAQ:PSTV (5/3/2024, 7:13:50 PM)

1.8

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.70M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-116.97%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.43

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.92
Quick Ratio	0.92
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)64.05%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y45.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2133.18%

Revenue growth 3Y153.95%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

Scheduled Maintenance

PLUS THERAPEUTICS INC (PSTV)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens